3 Marijuana Stocks To Watch As Featured On The Motley Fool

Subsys, used for breakthrough cancer pain in opioid-tolerant patients, is by far the company’s biggest-selling product, accounting for over 99% of total revenue. Insys also sells generic Dronabinol SG, a second-line cannabinoid drug used for chemotherapy-induced nausea and vomiting and anorexia associated with weight loss in... more →
Posted in: News

Pot Stocks That May Not Make It Through & Will Go Up In Smoke

Todd Campbell : Although Insys Therapeutics has a pipeline that doesn’t rely solely on medical marijuana, it is researching the use of CBD as a therapy for some rare forms of epilepsy and as a treatment for brain cancer. That research is pretty early stage and that means there are plenty of things that could go wrong. Investors... more →
Posted in: Investing

State Governor Just Exposed Greatest Weakness Of Marijuana

Another key point is that marijuana stocks are heavily reliant on emotions, much like the current momentum behind the marijuana movement. This can lead to wild and unsettling volatility for investors. Lastly, with the exception of Insys Therapeutics , there doesn’t appear to be a marijuana company that’s poised to turn... more →
Posted in: Investing

You Should Be Aware Of Marijuana Stocks

Douglass: Yes, and when you look at that revenue differential — again, just quoting Yahoo! Finance — GW Pharma‘s is under $50 million for the trailing 12 months, and Insys’ is right around $200 million, so you have the same valuation on 4x the sales. Okay, that may be a better opportunity for folks. You can... more →
Posted in: Investing

There Is Another Good Reason Why Buying This Marijuana Stock Is Good

Those two indications are small, with patient populations totaling just a few thousand, but both conditions have limited treatment options. As a result, the FDA has granted Insys orphan drug status on its CBD programs for those indications, which could help Insys bring those drugs to the market more quickly. Insys expects to conduct... more →
Posted in: Investing